Consumer Group Calls For Celebrex Ban
478662
NEW YORK -- Consumer group Public Citizen is calling on the government to ban the drug Celebrex. On Friday, drug maker Pfizer said the arthritis painkiller could increase the risk of a heart attack or a stroke if taken in very large doses.
47457
Researchers at The University of Alabama at Birmingham are telling hundreds of patients participating in a dozen clinical studies to quit taking Celebrex while authorities determine whether the arthritis medication is safe.
742151
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.    One key researcher charged the U.S...
85822
Pfizer plans to immediately stop advertising Celebrex, its best-selling arthritis pain reliever, to consumers after a study linked it to an increased risk of heart attacks.
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
157454
U.S. health regulators recommended  on Thursday that doctors limit prescribing painkillers like  Pfizer Inc.'s Celebrex and Bextra, in light of recent evidence  that they may increase the risk of heart attack and stroke.
627061
A PAINKILLER for arthritis sufferers should have been banned four years ago, experts said yesterday. Vioxx, used by 400,000 Brits, was taken off the market by its US makers last month due to potentially deadly side-effects.
177782
A U.S. consumer group on Monday accused Pfizer Inc. of burying a study suggesting its painkiller Celebrex boosts the risk of heart attack and stroke, a claim the No. 1 drug maker has denied.
16752
Drug giant Pfizer is to stop advertising its best-selling arthritis pain reliever Celebrex after a study showed high doses of it were associated with an increased heart attack risk.
131494
(Undated) Oct. 19, 2004 - The maker of arthritis drug Celebrex is launching a study to see if the drug has the same dangerous side effects that took Vioxx off the market.
514972
Patients who were switched from the prescription pain reliever Vioxx, taken off the market in September, to Celebrex or Aleve want to know what they should do now that the safety of both alternatives is being questioned.
641280
The Food and Drug Administration should immediately yank Celebrex and Bextra from the market to protect Americans from the drugs' heart risks, according to a petition filed with the agency yesterday by Public Citizen. The petition also requests that the FDA freeze applications for Arcoxia and Prexige -- two painkillers under development -- for the same reason.
272490
The US Food and Drug Administration is recommending physicians limit prescriptions for popular painkillers known as Cox-2 inhibitors after recent studies suggested they may increase the risk of heart attacks and strokes.
230112
Pfizer Inc. is indefinitely suspending all consumer advertising of its arthritis drug Celebrex, following last week&#39;s revelation of a study that showed high doses caused an increased risk of heart attacks among cancer patients.
180535
A consumer group asked a U.S. court on Thursday to force regulators to decide if stronger warnings should be added to certain antibiotics to alert doctors and patients about the risks of tendon rupture.
157316
A consumer group and 35 doctors and scientists asked the federal government Thursday to convene an independent review of the science that led to new guidelines urging wider use of cholesterol-lowering statin drugs.
122706
By Alice Dembner and Stephen Smith, Globe Staff | December 22, 2004. Doctors urged consumers yesterday not to overreact to the potential heart risks of naproxen, saying they are skeptical about research findings